Company: BIVIW
Filing Date: 2025-07-03
Form Type: S-1
Source: 0001520138-25-000198
Chunk: 2

Company: BIOVIE INC.
Filing Date: 2025-07-03
Form: S-1
Chunk 2
---
 Warrant to Purchase One Share of Class A Common Stock and One Warrant to Purchase One Share of Class A Common Stock

1,456,310 Shares of Class A Common Stock Underlying the Warrants

1,456,310 Shares of Class A Common Stock Underlying the Pre-Funded Warrants

BioVie Inc.

We are offering 1,456,310 units (“Units”)
in a firm commitment underwritten offering, with each Unit consisting of (i) one share of Class A Common Stock, par value $0.0001 per
share (the “Common Stock”), and (ii) one warrant to purchase one share of Common Stock (“Warrant”) at an assumed
public offering price of $10.30 per Unit, the last reported sale price of our Common Stock as reported on The Nasdaq Capital Market (“Nasdaq”)
on June 26, 2025. The actual public offering price per Unit will be determined between us and the underwriters at the time of pricing
and may be at a discount to this assumed offering price. Therefore, the assumed public offering price used throughout this prospectus
may not be indicative of the actual public offering price.

We are also offering 1,456,310 pre-funded
units (the “Pre-funded Units”), with each Pre-funded Unit consisting of (i) one pre-funded warrant (“Pre-funded Warrant”)
to purchase one share of our Common Stock and (ii) one Warrant to purchase one share of Common Stock, to those purchasers whose purchase
of Units in this offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially
owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding shares of Common Stock immediately following the
consummation of this offering. The purchase price of each Pre-funded Unit is equal to the price per Unit being sold to the public in this
offering, minus $0.0001.

Each Warrant will entitle the holder to purchase
one share of Common Stock at an exercise price of $12.875 (representing 125% of the assumed public offering price of $10.30 per Unit,
the last reported sale price of our Common Stock as reported on Nasdaq on June 26, 2025) and expire five (5) years from date
of issuance. Each Pre-funded Warrant will be immediately exercisable and may be exercised at any time until